A citation-based method for searching scientific literature

Elisa Gobbini, Aurélie Swalduz, Matteo Giaj Levra, Sandra Ortiz-Cuaran, Anne-Claire Toffart, Maurice Pérol, Denis Moro-Sibilot, Pierre Saintigny. Cancers (Basel) 2020
Times Cited: 8







List of co-cited articles
32 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Circulating mutant DNA to assess tumor dynamics.
Frank Diehl, Kerstin Schmidt, Michael A Choti, Katharine Romans, Steven Goodman, Meng Li, Katherine Thornton, Nishant Agrawal, Lori Sokoll, Steve A Szabo,[...]. Nat Med 2008
50

ctDNA and CTCs in Liquid Biopsy - Current Status and Where We Need to Progress.
Martin H D Neumann, Sebastian Bender, Thomas Krahn, Thomas Schlange. Comput Struct Biotechnol J 2018
105
50

Detection of circulating tumor DNA in early- and late-stage human malignancies.
Chetan Bettegowda, Mark Sausen, Rebecca J Leary, Isaac Kinde, Yuxuan Wang, Nishant Agrawal, Bjarne R Bartlett, Hao Wang, Brandon Luber, Rhoda M Alani,[...]. Sci Transl Med 2014
50

An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage.
Aaron M Newman, Scott V Bratman, Jacqueline To, Jacob F Wynne, Neville C W Eclov, Leslie A Modlin, Chih Long Liu, Joel W Neal, Heather A Wakelee, Robert E Merritt,[...]. Nat Med 2014
37

Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA.
Sarah B Goldberg, Azeet Narayan, Adam J Kole, Roy H Decker, Jimmitti Teysir, Nicholas J Carriero, Angela Lee, Roxanne Nemati, Sameer K Nath, Shrikant M Mane,[...]. Clin Cancer Res 2018
177
37

Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review.
Jason D Merker, Geoffrey R Oxnard, Carolyn Compton, Maximilian Diehn, Patricia Hurley, Alexander J Lazar, Neal Lindeman, Christina M Lockwood, Alex J Rai, Richard L Schilsky,[...]. J Clin Oncol 2018
419
37

Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer.
J Tie, I Kinde, Y Wang, H L Wong, J Roebert, M Christie, M Tacey, R Wong, M Singh, C S Karapetis,[...]. Ann Oncol 2015
355
37

Evaluation of commercial kits for purification of circulating free DNA.
Russell J Diefenbach, Jenny H Lee, Richard F Kefford, Helen Rizos. Cancer Genet 2018
50
37

Repeated mutKRAS ctDNA measurements represent a novel and promising tool for early response prediction and therapy monitoring in advanced pancreatic cancer.
S Kruger, V Heinemann, C Ross, F Diehl, D Nagel, S Ormanns, S Liebmann, I Prinz-Bravin, C B Westphalen, M Haas,[...]. Ann Oncol 2018
62
25

Technical considerations for circulating tumor DNA detection in oncology.
Claire Franczak, Pierre Filhine-Tresarrieu, Pauline Gilson, Jean-Louis Merlin, Lewis Au, Alexandre Harlé. Expert Rev Mol Diagn 2019
16
25

Non-invasive early detection of cancer four years before conventional diagnosis using a blood test.
Xingdong Chen, Jeffrey Gole, Athurva Gore, Qiye He, Ming Lu, Jun Min, Ziyu Yuan, Xiaorong Yang, Yanfeng Jiang, Tiejun Zhang,[...]. Nat Commun 2020
112
25

Liquid biopsies come of age: towards implementation of circulating tumour DNA.
Jonathan C M Wan, Charles Massie, Javier Garcia-Corbacho, Florent Mouliere, James D Brenton, Carlos Caldas, Simon Pacey, Richard Baird, Nitzan Rosenfeld. Nat Rev Cancer 2017
25

Detection and localization of surgically resectable cancers with a multi-analyte blood test.
Joshua D Cohen, Lu Li, Yuxuan Wang, Christopher Thoburn, Bahman Afsari, Ludmila Danilova, Christopher Douville, Ammar A Javed, Fay Wong, Austin Mattox,[...]. Science 2018
25

Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA.
Alain R Thierry, Florent Mouliere, Safia El Messaoudi, Caroline Mollevi, Evelyne Lopez-Crapez, Fanny Rolet, Brigitte Gillet, Celine Gongora, Pierre Dechelotte, Bruno Robert,[...]. Nat Med 2014
428
25

Integrated digital error suppression for improved detection of circulating tumor DNA.
Aaron M Newman, Alexander F Lovejoy, Daniel M Klass, David M Kurtz, Jacob J Chabon, Florian Scherer, Henning Stehr, Chih Long Liu, Scott V Bratman, Carmen Say,[...]. Nat Biotechnol 2016
534
25

Extending Circulating Tumor DNA Analysis to Ultralow Abundance Mutations: Techniques and Challenges.
Andrew E Rodda, Bradyn J Parker, Andrew Spencer, Simon R Corrie. ACS Sens 2018
17
25


Circulating tumor DNA and liquid biopsy: opportunities, challenges, and recent advances in detection technologies.
Lena Gorgannezhad, Muhammad Umer, Md Nazmul Islam, Nam-Trung Nguyen, Muhammad J A Shiddiky. Lab Chip 2018
123
25

Liquid biopsies: genotyping circulating tumor DNA.
Luis A Diaz, Alberto Bardelli. J Clin Oncol 2014
25

Early stage NSCLC - challenges to implementing ctDNA-based screening and MRD detection.
Christopher Abbosh, Nicolai J Birkbak, Charles Swanton. Nat Rev Clin Oncol 2018
140
25

Assessment of Blood Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Patients With Non-Small Cell Lung Cancer With Use of a Next-Generation Sequencing Cancer Gene Panel.
Zhijie Wang, Jianchun Duan, Shangli Cai, Miao Han, Hua Dong, Jun Zhao, Bo Zhu, Shuhang Wang, Minglei Zhuo, Jianguo Sun,[...]. JAMA Oncol 2019
231
25

Circulating Cell Free Tumor DNA Detection as a Routine Tool forLung Cancer Patient Management.
Julie A Vendrell, Frédéric Tran Mau-Them, Benoît Béganton, Sylvain Godreuil, Peter Coopman, Jérôme Solassol. Int J Mol Sci 2017
61
25

How liquid biopsies can change clinical practice in oncology.
G Siravegna, B Mussolin, T Venesio, S Marsoni, J Seoane, C Dive, N Papadopoulos, S Kopetz, R B Corcoran, L L Siu,[...]. Ann Oncol 2019
109
25

Clinical utility of circulating non-coding RNAs - an update.
Simone Anfossi, Anna Babayan, Klaus Pantel, George A Calin. Nat Rev Clin Oncol 2018
217
25

Exosome-based liquid biopsies in cancer: opportunities and challenges.
W Yu, J Hurley, D Roberts, S K Chakrabortty, D Enderle, M Noerholm, X O Breakefield, J K Skog. Ann Oncol 2021
63
25

Clinical relevance of circulating cell-free microRNAs in cancer.
Heidi Schwarzenbach, Naohiro Nishida, George A Calin, Klaus Pantel. Nat Rev Clin Oncol 2014
684
25

Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling.
Aadel A Chaudhuri, Jacob J Chabon, Alexander F Lovejoy, Aaron M Newman, Henning Stehr, Tej D Azad, Michael S Khodadoust, Mohammad Shahrokh Esfahani, Chih Long Liu, Li Zhou,[...]. Cancer Discov 2017
367
25

Tissue-Plasma TMB Comparison and Plasma TMB Monitoring in Patients With Metastatic Non-small Cell Lung Cancer Receiving Immune Checkpoint Inhibitors.
Alex Friedlaender, Thierry Nouspikel, Yann Christinat, Liza Ho, Thomas McKee, Alfredo Addeo. Front Oncol 2020
21
25

Monitoring Daily Dynamics of Early Tumor Response to Targeted Therapy by Detecting Circulating Tumor DNA in Urine.
Hatim Husain, Vladislava O Melnikova, Karena Kosco, Brian Woodward, Soham More, Sandeep C Pingle, Elizabeth Weihe, Ben Ho Park, Muneesh Tewari, Mark G Erlander,[...]. Clin Cancer Res 2017
68
25

Clearing of circulating tumour DNA predicts clinical response to first line tyrosine kinase inhibitors in advanced epidermal growth factor receptor mutated non-small cell lung cancer.
Eva Boysen Fynboe Ebert, Tine McCulloch, Karin Holmskov Hansen, Hanne Linnet, Boe Sorensen, Peter Meldgaard. Lung Cancer 2020
11
25

ctDNA Predicts Overall Survival in Patients With NSCLC Treated With PD-L1 Blockade or With Chemotherapy.
Wei Zou, Stephanie J Yaung, Frederike Fuhlbrück, Marcus Ballinger, Eric Peters, John F Palma, David S Shames, David Gandara, Yuqiu Jiang, Namrata S Patil. JCO Precis Oncol 2021
6
33

The Use of Circulating Tumor DNA to Monitor and Predict Response to Treatment in Colorectal Cancer.
Mifanwy Reece, Hariti Saluja, Paul Hollington, Christos S Karapetis, Sina Vatandoust, Graeme P Young, Erin L Symonds. Front Genet 2019
36
25

Genetic profiling using plasma-derived cell-free DNA in therapy-naïve hepatocellular carcinoma patients: a pilot study.
C K Y Ng, G G Di Costanzo, N Tosti, V Paradiso, M Coto-Llerena, G Roscigno, V Perrina, C Quintavalle, T Boldanova, S Wieland,[...]. Ann Oncol 2018
48
12

Use of the Ion PGM and the GeneReader NGS Systems in Daily Routine Practice for Advanced Lung Adenocarcinoma Patients: A Practical Point of View Reporting a Comparative Study and Assessment of 90 Patients.
Simon Heeke, Véronique Hofman, Elodie Long-Mira, Virginie Lespinet, Salomé Lalvée, Olivier Bordone, Camille Ribeyre, Virginie Tanga, Jonathan Benzaquen, Sylvie Leroy,[...]. Cancers (Basel) 2018
9
12

Host nucleotide polymorphism in hepatitis B virus-associated hepatocellular carcinoma.
Shilu Mathew, Hany Abdel-Hafiz, Abbas Raza, Kaneez Fatima, Ishtiaq Qadri. World J Hepatol 2016
11
12

High Throughput Single Cell RNA Sequencing, Bioinformatics Analysis and Applications.
Xiaoyun Huang, Shiping Liu, Liang Wu, Miaomiao Jiang, Yong Hou. Adv Exp Med Biol 2018
16
12

Quercetin shows anti-tumor effect in hepatocellular carcinoma LM3 cells by abrogating JAK2/STAT3 signaling pathway.
Liwei Wu, Jingjing Li, Tong Liu, Sainan Li, Jiao Feng, Qiang Yu, Jie Zhang, Jiaojiao Chen, Yuting Zhou, Jie Ji,[...]. Cancer Med 2019
45
12

Selective capture of plasma cell-free tumor DNA on magnetic beads: a sensitive and versatile tool for liquid biopsy.
Mohammad Amin Kerachian, Marjan Azghandi, Ali Javadmanesh, Kamran Ghaffarzadegan, Sina Mozaffari-Jovin. Cell Oncol (Dordr) 2020
6
16

COLD-PCR Technologies in the Area of Personalized Medicine: Methodology and Applications.
Florence Mauger, Alexandre How-Kit, Jörg Tost. Mol Diagn Ther 2017
17
12

Droplet-Based Digital PCR: Application in Cancer Research.
G Perkins, H Lu, F Garlan, V Taly. Adv Clin Chem 2017
54
12

[Immune Response on Outcomes in Hepatocellular Carcinoma].
Norifumi Iseda, Shinji Itoh, Takahiro Tomiyama, Akinari Morinaga, Huanlin Wang, Tomonari Shimagaki, Takeshi Kurihara, Yoshihiro Nagao, Takeo Toshima, Noboru Harada,[...]. Gan To Kagaku Ryoho 2020
1
100

Circulating tumor DNA correlates with microvascular invasion and predicts tumor recurrence of hepatocellular carcinoma.
Jian Wang, Ao Huang, Yu-Peng Wang, Yue Yin, Pei-Yao Fu, Xin Zhang, Jian Zhou. Ann Transl Med 2020
13
12

Detection of T790M, the Acquired Resistance EGFR Mutation, by Tumor Biopsy versus Noninvasive Blood-Based Analyses.
Tilak K Sundaresan, Lecia V Sequist, John V Heymach, Gregory J Riely, Pasi A Jänne, Walter H Koch, James P Sullivan, Douglas B Fox, Robert Maher, Alona Muzikansky,[...]. Clin Cancer Res 2016
272
12

Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial.
Jordi Rodon, Jean-Charles Soria, Raanan Berger, Wilson H Miller, Eitan Rubin, Aleksandra Kugel, Apostolia Tsimberidou, Pierre Saintigny, Aliza Ackerstein, Irene Braña,[...]. Nat Med 2019
181
12

Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA.
Tim Forshew, Muhammed Murtaza, Christine Parkinson, Davina Gale, Dana W Y Tsui, Fiona Kaper, Sarah-Jane Dawson, Anna M Piskorz, Mercedes Jimenez-Linan, David Bentley,[...]. Sci Transl Med 2012
807
12

Nondestructive enzymatic deamination enables single-molecule long-read amplicon sequencing for the determination of 5-methylcytosine and 5-hydroxymethylcytosine at single-base resolution.
Zhiyi Sun, Romualdas Vaisvila, Laura-Madison Hussong, Bo Yan, Chloé Baum, Lana Saleh, Mala Samaranayake, Shengxi Guan, Nan Dai, Ivan R Corrêa,[...]. Genome Res 2021
16
12

Hypomethylation in HBV integration regions aids non-invasive surveillance to hepatocellular carcinoma by low-pass genome-wide bisulfite sequencing.
Haikun Zhang, Peiling Dong, Shicheng Guo, Chengcheng Tao, Wei Chen, Wenmin Zhao, Jiakang Wang, Ramsey Cheung, Augusto Villanueva, Jian Fan,[...]. BMC Med 2020
9
12

Circulating Tumour DNA for Monitoring Treatment Response to Anti-PD-1 Immunotherapy in Melanoma Patients.
Atsuko Ashida, Kaori Sakaizawa, Hisashi Uhara, Ryuhei Okuyama. Acta Derm Venereol 2017
22
12

Is serum level of methylated RASSF1A valuable in diagnosing hepatocellular carcinoma in patients with chronic viral hepatitis C?
Nadia A Mohamed, Eman M Swify, Nabila F Amin, Mona M Soliman, Lubna M Tag-Eldin, Nahla M Elsherbiny. Arab J Gastroenterol 2012
27
12

Hepatocellular Carcinoma Detection by Plasma Methylated DNA: Discovery, Phase I Pilot, and Phase II Clinical Validation.
John B Kisiel, Brian A Dukek, Reddappa V S R Kanipakam, Hassan M Ghoz, Tracy C Yab, Calise K Berger, William R Taylor, Patrick H Foote, Nasra H Giama, Kristeen Onyirioha,[...]. Hepatology 2019
65
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.